{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:04:31Z","timestamp":1776089071958,"version":"3.50.1"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_cclm-2021-0694_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We hypothesized that the amount of antigen produced in the body during a COVID-19 infection might differ between patients, and that maximum concentrations would predict the degree of both inflammation and outcome for patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2021-0694_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Eighty-four hospitalized and SARS-CoV-2 PCR swab-positive patients, were followed with blood sampling every day until discharge or death. A total of 444 serial EDTA plasma samples were analyzed for a range of biomarkers: SARS-CoV-2 nuclear antigen and RNA concentration, complement activation as well as several inflammatory markers, and KL-6 as a lung marker. The patients were divided into outcome groups depending on need of respiratory support and death\/survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2021-0694_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Circulating SARS-CoV-2 nuclear antigen levels were above the detection limit in blood in 65 out of 84 COVID-19 PCR swab-positive patients on day one of hospitalization, as was viral RNA in plasma in 30 out of 84. In all patients, complete antigen clearance was observed within 24\u00a0days. There were definite statistically significant differences between the groups depending on their biomarkers, showing that the concentrations of virus RNA and antigen were correlated to the inflammatory biomarker levels, respiratory treatment and death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2021-0694_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Viral antigen is cleared in parallel with the virus RNA levels. The levels of antigens and SARS-CoV-2 RNA in the blood correlates with the level of IL-6, inflammation, respiratory failure and death. We propose that the antigens levels together with RNA in blood can be used to predict the severity of disease, outcome, and the clearance of the virus from the body.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/cclm-2021-0694","type":"journal-article","created":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T04:40:40Z","timestamp":1630212040000},"page":"1988-1997","source":"Crossref","is-referenced-by-count":38,"title":["Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19"],"prefix":"10.1515","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-2449","authenticated-orcid":false,"given":"Claus Lohman","family":"Brasen","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"},{"name":"Department of Regional Health Research , University of Southern Denmark , Odense , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte A.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Kahns","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke F.","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeppe B.","family":"Madsen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Lassen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Kierkegaard","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas V.","family":"Sydenham","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"},{"name":"Department of Regional Health Research , University of Southern Denmark , Odense , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna S.","family":"Madsen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"},{"name":"Department of Regional Health Research , University of Southern Denmark , Odense , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens K.","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"},{"name":"Department of Regional Health Research , University of Southern Denmark , Odense , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Brandslund","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology , Lillebaelt Hospital, University Hospital of Southern Denmark , Vejle , Denmark"},{"name":"Department of Regional Health Research , University of Southern Denmark , Odense , Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"2023033112143556651_j_cclm-2021-0694_ref_001","doi-asserted-by":"crossref","unstructured":"Fajgenbaum, DC, June, CH. Cytokine storm. N Engl J Med 2020;383:2255\u201373. https:\/\/doi.org\/10.1056\/nejmra2026131.","DOI":"10.1056\/NEJMra2026131"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_002","doi-asserted-by":"crossref","unstructured":"Triggle, CR, Bansal, D, Ding, H, Islam, MM, Farag, E, Hadi, HA, et al.. A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol 2021;12:631139. https:\/\/doi.org\/10.3389\/fimmu.2021.631139.","DOI":"10.3389\/fimmu.2021.631139"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_003","doi-asserted-by":"crossref","unstructured":"Magro, C, Mulvey, JJ, Berlin, D, Nuovo, G, Salvatore, S, Harp, J, et al.. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020;220:1\u201313. https:\/\/doi.org\/10.1016\/j.trsl.2020.04.007.","DOI":"10.1016\/j.trsl.2020.04.007"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_004","unstructured":"Online. Corticosteroids for COVID-19. WHO-recommendations [Internet]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1."},{"key":"2023033112143556651_j_cclm-2021-0694_ref_005","doi-asserted-by":"crossref","unstructured":"Pallisgaard, N, Spindler, KL, Andersen, RF, Brandslund, I, Jakobsen, A. Controls to validate plasma samples for cell free DNA quantification. Clin Chim Acta 2015;446:141\u20136. https:\/\/doi.org\/10.1016\/j.cca.2015.04.015.","DOI":"10.1016\/j.cca.2015.04.015"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_006","doi-asserted-by":"crossref","unstructured":"Brandslund, I, Teisner, B, Hyltoft Petersen, P, Svehag, SE. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d. Scand J Clin Lab Invest Suppl 1984;168:57\u201373. https:\/\/doi.org\/10.3109\/00365518409088734.","DOI":"10.3109\/00365518409088734"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_007","doi-asserted-by":"crossref","unstructured":"Bermejo-Martin, JF, Gonzalez-Rivera, M, Almansa, R, Micheloud, D, Tedim, AP, Dominguez-Gil, M, et al.. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care 2020;24:691. https:\/\/doi.org\/10.1186\/s13054-020-03398-0.","DOI":"10.1186\/s13054-020-03398-0"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_008","unstructured":"Brandslund, I, Peters, ND, Ejstrup, L. Steroids reduce complement activation in rheumatoid arthritis. Int J Tissue React 1985;7:161\u20135."},{"key":"2023033112143556651_j_cclm-2021-0694_ref_009","doi-asserted-by":"crossref","unstructured":"Group, RC, Horby, P, Lim, WS, Emberson, JR, Mafham, M, Bell, JL, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693\u2013704. https:\/\/doi.org\/10.1056\/nejmoa2021436.","DOI":"10.1056\/NEJMoa2021436"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_010","doi-asserted-by":"crossref","unstructured":"Jamaati, H, Hashemian, SM, Farzanegan, B, Malekmohammad, M, Tabarsi, P, Marjani, M, et al.. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial. Eur J Pharmacol 2021;897:173947. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173947.","DOI":"10.1016\/j.ejphar.2021.173947"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_011","unstructured":"Online. Higher vs. lower doses of dexamethasone in patients with COVID-19 and severe hypoxia. Clinical trials.gov [Internet]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04509973."},{"key":"2023033112143556651_j_cclm-2021-0694_ref_012","doi-asserted-by":"crossref","unstructured":"d\u2019Alessandro, M, Bergantini, L, Cameli, P, Curatola, G, Remediani, L, Bennett, D, et al.. Serial KL-6 measurements in COVID-19 patients. Intern Emerg Med 2021;16:1541\u20131545. https:\/\/doi.org\/10.1007\/s11739-020-02614-7.","DOI":"10.1007\/s11739-020-02614-7"},{"key":"2023033112143556651_j_cclm-2021-0694_ref_013","doi-asserted-by":"crossref","unstructured":"Friedl, A, Stoesz, SP, Buckley, P, Gould, MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 1999;31:433\u201341. https:\/\/doi.org\/10.1023\/a:1003708808934.","DOI":"10.1023\/A:1003708808934"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2021-0694\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2021-0694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T16:35:36Z","timestamp":1680280536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2021-0694\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":13,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6,23]]},"published-print":{"date-parts":[[2021,11,25]]}},"alternative-id":["10.1515\/cclm-2021-0694"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2021-0694","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}